EU Needs ‘Agile & Enabling Ecosystem’ To Address Decline In Clinical Trials

The EU Clinical Trials Regulation has “so far failed to improve Europe’s competitiveness,” according to a new report commissioned by the pharmaceutical industry body EFPIA.

Red arrow descending
Europe's pharma industry wants action to address the decline in clinical trial activity (Shutterstock)

More from Clinical Trials

More from Geography